LER & CER: letter to Editor Rheumatology

Exploring the ‘risk’: Comments on the FAERS data regarding the safety of JAK inhibitors by Mikaeili et al.

E. Bilgin¹

Division of Rheumatology, Department of Internal Medicine, Sakarya University Faculty of Medicine, Sakarya, Turkey. emrebilgin@sakarya.edu.tr

CER18806
LER & CER: letter to Editor Rheumatology

Free to view
(click on article PDF icon to read the article)

PMID: 40470556 [PubMed]

Received: 07/04/2025
Accepted : 14/05/2025
In Press: 15/05/2025